Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesRensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
EurekAlert, 09/18/09
In early 2008, there was a frightening failure in drug safety processes. In just a few weeks, more than 100 Americans had died after being administered contaminated doses of the common blood thinner heparin. The contaminant, present in heparin manufactured in China and discovered with the help of scientists from Rensselaer Polytechnic Institute, was so structurally similar to pure heparin that is was undetectable to all but the most sophisticated detection techniques. As a result, many people became seriously ill or died around the world and the several hundred thousand patients that receive the drug every day in the U.S. were put at risk.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Negative emotions outweigh intent to exercise at health clubs
ScienceDaily, 12/18/09
Breakthrough May Pave the Way for Therapeutic Vaccines
ScienceDaily, 12/18/09
Should flowers be banned in hospitals?
ScienceDaily, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor